Abstract:To elucidate the antileukemi effects of berbamine and the possible molecular mechanisms in vitro and in vivo, MTT method was used to examine the effect of berbamine on K562 cell growth. The apoptosis rate was measured by flow cytometry. The mRNA expression level of BCR/ABL gene (semiquantity value) was determined by RT-PCR and the BCR/ABL protein (P210) level was detected by Western blot. The K562-bearing mice were used to reveal the therapeutic effect in vivo. The results showed that a significant time- and concentration-dependent inhibition of cell growth was found in the cells treated with berbamine. After the cells were exposed to 8.0 microg/ml berbamine for 24, 48 and 72 hours, the percentage of growth inhibition of K562 cells progressively increased by (26.63 +/- 3.57)%, (61.84 +/- 4.74)%, (75.32 +/- 1.95)%, respectively (compared with control, P < 0.01). The IC(50) (72 hours) value was 5.227 +/- 1.307 microg/ml. The apoptosis rate of K562 cells treated with 8.0 microg/ml berbamine for 24 and 72 hours increased from (29.20 +/- 3.82)% to (61.77 +/- 4.35)% (P < 0.01). Berbamine down-regulated the expression levels of bcr/abl gene and P210 in K562 cells in a time- and concentration-dependent manner. The bcr/abl expression decreased from (1.38 +/- 0.02) to (0.97 +/- 0.01) after exposure of the cells to 8.0 microg/ml berbamine for 0 and 72 hours (P < 0.01). When the cells were treated with 4.0 - 16.0 microg/ml berbamine for 24 hours, the level of P210 decreased from (0.95 +/- 0.03) to (0.63 +/- 0.01) (P < 0.01). In vivo, after treatment for 4 weeks, the tumor weight of berbamine-treated group was also lower than that of untreated group [(1.46 +/- 0.43) g vs (2.90 +/- 0.94) g, P < 0.01] and the inhibition rate was 49.66%, moreover, berbamine down-regulated the expression level of bcr/abl gene of tumor cells. It is concluded that berbamine can obviously inhibit the cell proliferation and induce apoptosis in K562 cell lines in a time- and concentration-dependent manner in vitro. The mechanisms of berbamine-induced apoptosis may be involved in down-regulation of bcr/abl gene expression and P210 level. In vivo, berbamine can aslo display a better antileukemic effect and down-regulate expression of bcr/abl gene. Berbamine extracted from Chinese herb may be a promising candidate of new drug for clinical anticancer treatment, especially for bcr-abl(+) diseases.

Anticancer Effects of ZWM233 in Vitro and Its Mechanisms

[Effects of Berbamine on K562 Cells and Its Mechanisms in Vitro and in Vivo].

Berbamine Exhibits Potent Antitumor Effects on Imatinib-Resistant CML Cells in Vitro and in Vivo

Antiproliferative Effect of ZSTK474 Alone or in Combination with Chemotherapeutic Drugs on HL60 and HL60/ADR Cells

Effect of PI3K/Akt Inhibitor Wortmannin on Proliferation and Apoptosis of Leukemia K562 Cells

Anticancer potential of Bacillus coagulans MZY531 on mouse H22 hepatocellular carcinoma cells via anti-proliferation and apoptosis induction

[CML Cell Line K562 Cell Apoptosis Induced by Mangiferin].

[Effect of ZD6474 on the Proliferation of Imatinib-Resistant K562 Cells].

Mz3 Can Induce G2/M-Phase Arrest and Apoptosis in Human Leukemia Cells

Anticancer Mechanism and Effect of New Platinum(ii) Complex on the Human Cancer Cells

Anti-tumor Activities of Pyrazole Derivatives in Vitro

Apoptosis Induction of ZBB-006, a Novel Synthetic Diterpenoid, in the Human Hepatocellular Carcinoma Cell Line HepG2 in Vitro and in Vivo.

Apoptosis of Leukemic Cells Induced by Flavonoids of Puerarin and Its Molecular Mechanisms

[The Role of Src Kinase Inhibitor ZD6474 on Multi-Drug Resistant K562/A02 Cells].

Study on Apoptosis of K562 Cells of Chronic Myelocytic Leukemia Induced by ACT23-21

THE MECHANISM OF ZD1839 IN PANCREATIC CNACER CELLS INHIBITION

Effects of the Multidrug Resistance Modulator HZ08 on the Apoptosis Pathway in Human Chronic Leukaemia Cell Line K562/A02

Identification of an Antitumor Effect of Demethylzeylasteral on Human Gastric Cancer Cells.

Effects of betulinic acid on proliferation and apoptosis in Jurkat cells and its in vitro mechanism

DCZ0801, a Novel Compound, Induces Cell Apoptosis and Cell Cycle Arrest Via MAPK Pathway in Multiple Myeloma.

[Effect of Betulinic Acid on Proliferation and Apoptosis in Jurkat Cells and Its Mechanism].